News Focus
News Focus
Followers 76
Posts 6476
Boards Moderated 0
Alias Born 05/25/2021

Re: None

Wednesday, 01/17/2024 11:04:22 AM

Wednesday, January 17, 2024 11:04:22 AM

Post# of 824192
A new building is about to start at West Point Merck Campus which will be full of sample testing labs.

The applicant, Merck Sharp, & Dohme, submitted a Preliminary/final Land Development application to the Township on November 17, 2023 for the Merck West Point Campus, located at 770 Sumneytown Pike. The applicant proposes to construct a 110,600 square foot building on a footprint of 40,300 Square feet. The building will be 3 floors; 1st floor consisting of 2 loading docks, 2nd floor consisting of sample testing labs, cold storage, and offices, the 3rd floor consisting of sample testing labs, office space, and shell space. The building exterior will be insulated metal clad panels with glass, located 850 feet from Sumneytown Pike and 800 feet from West Point Pike. The proposal also addressed on-site parking, connection to local in-place facilities, and landscaping. This new building will be occupied by 180 staff members, a mix of transfers and new employees.



https://www.uppergwynedd.org/sites/g/files/vyhlif1351/f/uploads/merck_b41_ld_approval.pdf

“The world is waiting for the next big thing — innovations that will help confront the tremendous burden of disease for patients. Addressing those diseases requires the kind of world-class, scientific exploration that we are pursuing.”



https://www.merck.com/stories/why-were-expanding-and-investing-in-our-research-and-discovery-efforts/

While some Merck & Co. investors may still get the heebie-jeebies when thinking about Keytruda’s patent cliff in 2028, but the company’s CEO Rob Davis now thinks “it’s just another year.”



https://www.fiercepharma.com/pharma/jpm24-merck-expects-over-20b-post-keytruda-sales-new-cancer-drugs-thanks-daiichi-adc-deal
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News